Sentence	entity_1	entity_2	entity_3	entity_4	entity_5	entity_6	entity_7	json	split
In the present study we investigated the possible involvement of the mitogen - activated protein kinase family members extracellular - regulated kinase 1 / 2 ( ERK1 / 2) and c - Jun N - terminal kinase ( JNK) in mediating IL - 6 gene expression in human monocytes, in particular their role in enhancing NF - kappa B activity.	extracellular - regulated kinase 1,119,153,Protein	2,156,157,Protein	ERK1,160,164,Protein	2,167,168,Protein	c - Jun N - terminal kinase,174,201,Protein	JNK,204,207,Protein	IL - 6,222,228,Protein	"[{""token"": ""extracellular - regulated kinase 1"", ""start_span"": 119, ""end_span"": 153, ""type"": ""Protein""}, {""token"": ""2"", ""start_span"": 156, ""end_span"": 157, ""type"": ""Protein""}, {""token"": ""ERK1"", ""start_span"": 160, ""end_span"": 164, ""type"": ""Protein""}, {""token"": ""2"", ""start_span"": 167, ""end_span"": 168, ""type"": ""Protein""}, {""token"": ""c - Jun N - terminal kinase"", ""start_span"": 174, ""end_span"": 201, ""type"": ""Protein""}, {""token"": ""JNK"", ""start_span"": 204, ""end_span"": 207, ""type"": ""Protein""}, {""token"": ""IL - 6"", ""start_span"": 222, ""end_span"": 228, ""type"": ""Protein""}]"	train
Th1 cells produce IL - 2 and IFN - gamma, whereas Th2 cells produce IL - 4, IL - 5, IL - 6, IL - 10, and IL - 13.	IL - 2,18,24,Protein	IFN - gamma,29,40,Protein	IL - 4,68,74,Protein	IL - 5,76,82,Protein	IL - 6,84,90,Protein	IL - 10,92,99,Protein	IL - 13,105,112,Protein	"[{""token"": ""IL - 2"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 29, ""end_span"": 40, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 68, ""end_span"": 74, ""type"": ""Protein""}, {""token"": ""IL - 5"", ""start_span"": 76, ""end_span"": 82, ""type"": ""Protein""}, {""token"": ""IL - 6"", ""start_span"": 84, ""end_span"": 90, ""type"": ""Protein""}, {""token"": ""IL - 10"", ""start_span"": 92, ""end_span"": 99, ""type"": ""Protein""}, {""token"": ""IL - 13"", ""start_span"": 105, ""end_span"": 112, ""type"": ""Protein""}]"	train
In addition, sodium salicylate and additional NSAIDs used at concentrations that activate HSF1 also inhibited the expression of other monocytic genes ( TNF - alpha, IL - 1beta, IL - 6, IL - 8, IL - 10, ICAM - 1) activated by exposure to a pro - inflammatory stimulus ( lipopolysaccharide, LPS).	HSF1,90,94,Protein	TNF - alpha,152,163,Protein	IL - 1beta,165,175,Protein	IL - 6,177,183,Protein	IL - 8,185,191,Protein	IL - 10,193,200,Protein	ICAM - 1,202,210,Protein	"[{""token"": ""HSF1"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 152, ""end_span"": 163, ""type"": ""Protein""}, {""token"": ""IL - 1beta"", ""start_span"": 165, ""end_span"": 175, ""type"": ""Protein""}, {""token"": ""IL - 6"", ""start_span"": 177, ""end_span"": 183, ""type"": ""Protein""}, {""token"": ""IL - 8"", ""start_span"": 185, ""end_span"": 191, ""type"": ""Protein""}, {""token"": ""IL - 10"", ""start_span"": 193, ""end_span"": 200, ""type"": ""Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 202, ""end_span"": 210, ""type"": ""Protein""}]"	train
In this study, we demonstrate reconstitution of a cell - free processing system and demonstrate directly that: ( a) the ubiquitin - proteasome system is involved in processing of the intact p105 precursor, ( b) conjugation of ubiquitin to the precursor is an essential intermediate step in the processing, ( c) the recently discovered novel species of the ubiquitin - carrier protein, E2 - F1, that is involved in the conjugation and degradation of p53, is also required for the limited processing of the p105 precursor, and ( d) a novel, approximately 320 - kDa species of ubiquitin - protein ligase, is involved in the process.	ubiquitin,120,129,Protein	p105,190,194,Protein	ubiquitin,226,235,Protein	E2 - F1,385,392,Protein	p53,449,452,Protein	p105,505,509,Protein	ubiquitin,574,583,Protein	"[{""token"": ""ubiquitin"", ""start_span"": 120, ""end_span"": 129, ""type"": ""Protein""}, {""token"": ""p105"", ""start_span"": 190, ""end_span"": 194, ""type"": ""Protein""}, {""token"": ""ubiquitin"", ""start_span"": 226, ""end_span"": 235, ""type"": ""Protein""}, {""token"": ""E2 - F1"", ""start_span"": 385, ""end_span"": 392, ""type"": ""Protein""}, {""token"": ""p53"", ""start_span"": 449, ""end_span"": 452, ""type"": ""Protein""}, {""token"": ""p105"", ""start_span"": 505, ""end_span"": 509, ""type"": ""Protein""}, {""token"": ""ubiquitin"", ""start_span"": 574, ""end_span"": 583, ""type"": ""Protein""}]"	train
Expression and genomic configuration of GM - CSF, IL - 3, M - CSF receptor ( C - FMS), early growth response gene - 1 ( EGR - 1) and M - CSF genes in primary myelodysplastic syndromes.	GM - CSF,40,48,Protein	IL - 3,50,56,Protein	M - CSF receptor,58,74,Protein	C - FMS,77,84,Protein	early growth response gene - 1,87,117,Protein	EGR - 1,120,127,Protein	M - CSF,133,140,Protein	"[{""token"": ""GM - CSF"", ""start_span"": 40, ""end_span"": 48, ""type"": ""Protein""}, {""token"": ""IL - 3"", ""start_span"": 50, ""end_span"": 56, ""type"": ""Protein""}, {""token"": ""M - CSF receptor"", ""start_span"": 58, ""end_span"": 74, ""type"": ""Protein""}, {""token"": ""C - FMS"", ""start_span"": 77, ""end_span"": 84, ""type"": ""Protein""}, {""token"": ""early growth response gene - 1"", ""start_span"": 87, ""end_span"": 117, ""type"": ""Protein""}, {""token"": ""EGR - 1"", ""start_span"": 120, ""end_span"": 127, ""type"": ""Protein""}, {""token"": ""M - CSF"", ""start_span"": 133, ""end_span"": 140, ""type"": ""Protein""}]"	train
This activation was due to the translocation of p65 and c - Rel NF. kappa B proteins from cytoplasmic stores to the nucleus, where they bound the kappa B sequence of the IL - 2R alpha promoter either as p50. p65 or as p50. c - Rel heterodimers.	p65,48,51,Protein	c - Rel,56,63,Protein	IL - 2R alpha,170,183,Protein	p50,203,206,Protein	p65,208,211,Protein	p50,218,221,Protein	c - Rel,223,230,Protein	"[{""token"": ""p65"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Protein""}, {""token"": ""c - Rel"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Protein""}, {""token"": ""IL - 2R alpha"", ""start_span"": 170, ""end_span"": 183, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 203, ""end_span"": 206, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 208, ""end_span"": 211, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 218, ""end_span"": 221, ""type"": ""Protein""}, {""token"": ""c - Rel"", ""start_span"": 223, ""end_span"": 230, ""type"": ""Protein""}]"	train
EBNA - 2 trans - activates cellular and viral genes like CD23, c - fgr, latent membrane protein 1 ( LMP1) and terminal protein 1 ( TP1).	EBNA - 2,0,8,Protein	CD23,57,61,Protein	c - fgr,63,70,Protein	latent membrane protein 1,72,97,Protein	LMP1,100,104,Protein	terminal protein 1,110,128,Protein	TP1,131,134,Protein	"[{""token"": ""EBNA - 2"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Protein""}, {""token"": ""CD23"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Protein""}, {""token"": ""c - fgr"", ""start_span"": 63, ""end_span"": 70, ""type"": ""Protein""}, {""token"": ""latent membrane protein 1"", ""start_span"": 72, ""end_span"": 97, ""type"": ""Protein""}, {""token"": ""LMP1"", ""start_span"": 100, ""end_span"": 104, ""type"": ""Protein""}, {""token"": ""terminal protein 1"", ""start_span"": 110, ""end_span"": 128, ""type"": ""Protein""}, {""token"": ""TP1"", ""start_span"": 131, ""end_span"": 134, ""type"": ""Protein""}]"	train
IL - 4 down - regulated mRNA accumulation of the proinflammatory cytokines IL - 1 beta, IL - 8, and TNF - alpha in monocytes stimulated with IL - 2, IL - 3, and GM - CSF.	IL - 4,0,6,Protein	IL - 1 beta,75,86,Protein	IL - 8,88,94,Protein	TNF - alpha,100,111,Protein	IL - 2,141,147,Protein	IL - 3,149,155,Protein	GM - CSF,161,169,Protein	"[{""token"": ""IL - 4"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Protein""}, {""token"": ""IL - 1 beta"", ""start_span"": 75, ""end_span"": 86, ""type"": ""Protein""}, {""token"": ""IL - 8"", ""start_span"": 88, ""end_span"": 94, ""type"": ""Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 100, ""end_span"": 111, ""type"": ""Protein""}, {""token"": ""IL - 2"", ""start_span"": 141, ""end_span"": 147, ""type"": ""Protein""}, {""token"": ""IL - 3"", ""start_span"": 149, ""end_span"": 155, ""type"": ""Protein""}, {""token"": ""GM - CSF"", ""start_span"": 161, ""end_span"": 169, ""type"": ""Protein""}]"	train
Using fluorescence in situ hybridization ( FISH), we show here that the genes encoding the TATA - box binding protein ( TBP), TFIIB, TFIIE alpha, TFIIE beta, RAP30, RAP74 and the 62 kDa subunit, of TFIIH are located at the human chromosomal bands 6q26 - 27, 1p21 - 22, 3q21 - 24, 8p12, 13q14, 19p13. 3 and 11p14 - 15. 1, respectively.	TATA - box binding protein,91,117,Protein	TBP,120,123,Protein	TFIIB,126,131,Protein	TFIIE alpha,133,144,Protein	TFIIE beta,146,156,Protein	RAP30,158,163,Protein	RAP74,165,170,Protein	"[{""token"": ""TATA - box binding protein"", ""start_span"": 91, ""end_span"": 117, ""type"": ""Protein""}, {""token"": ""TBP"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Protein""}, {""token"": ""TFIIB"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Protein""}, {""token"": ""TFIIE alpha"", ""start_span"": 133, ""end_span"": 144, ""type"": ""Protein""}, {""token"": ""TFIIE beta"", ""start_span"": 146, ""end_span"": 156, ""type"": ""Protein""}, {""token"": ""RAP30"", ""start_span"": 158, ""end_span"": 163, ""type"": ""Protein""}, {""token"": ""RAP74"", ""start_span"": 165, ""end_span"": 170, ""type"": ""Protein""}]"	train
While p70I kappa B gamma inhibits p50 -, p65 -, and c - Rel - mediated transactivation and / or DNA binding, both I kappa B gamma - 1 and I kappa B gamma - 2 are specific for p50 and have different affinities for this subunit.	p70I kappa B gamma,6,24,Protein	p50,34,37,Protein	p65,41,44,Protein	c - Rel,52,59,Protein	I kappa B gamma - 1,114,133,Protein	I kappa B gamma - 2,138,157,Protein	p50,175,178,Protein	"[{""token"": ""p70I kappa B gamma"", ""start_span"": 6, ""end_span"": 24, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Protein""}, {""token"": ""c - Rel"", ""start_span"": 52, ""end_span"": 59, ""type"": ""Protein""}, {""token"": ""I kappa B gamma - 1"", ""start_span"": 114, ""end_span"": 133, ""type"": ""Protein""}, {""token"": ""I kappa B gamma - 2"", ""start_span"": 138, ""end_span"": 157, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 175, ""end_span"": 178, ""type"": ""Protein""}]"	train
Antibodies against the NF - kappa B and Rel proteins and UV cross - linking studies revealed the presence of c - Rel and p65 and the absence of p50 in the TF complex and further showed that c - Rel / p65 heterodimers selectively bound to the TF kappa B - like site.	c - Rel,109,116,Protein	p65,121,124,Protein	p50,144,147,Protein	TF,155,157,Protein	c - Rel,190,197,Protein	p65,200,203,Protein	TF,242,244,Protein	"[{""token"": ""c - Rel"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Protein""}, {""token"": ""TF"", ""start_span"": 155, ""end_span"": 157, ""type"": ""Protein""}, {""token"": ""c - Rel"", ""start_span"": 190, ""end_span"": 197, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 200, ""end_span"": 203, ""type"": ""Protein""}, {""token"": ""TF"", ""start_span"": 242, ""end_span"": 244, ""type"": ""Protein""}]"	train
In clonogenetic fetal calf serum - supplemented ( FCS +) or - nonsupplemented ( FCS -) culture treated with saturating levels of interleukin - 3 ( IL - 3) granulocyte - macrophage colony - stimulating factor ( GM - CSF) and erythropoietin ( Ep) ( combined with c - kit ligand in FCS ( -) - culture conditions), RA induces a dramatic dose - dependent shift from erythroid to granulomonocytic colony formation, the latter colonies being essentially represented by granulocytic clones.	interleukin - 3,129,144,Protein	IL - 3,147,153,Protein	granulocyte - macrophage colony - stimulating factor,155,207,Protein	GM - CSF,210,218,Protein	erythropoietin,224,238,Protein	Ep,241,243,Protein	c - kit ligand,261,275,Protein	"[{""token"": ""interleukin - 3"", ""start_span"": 129, ""end_span"": 144, ""type"": ""Protein""}, {""token"": ""IL - 3"", ""start_span"": 147, ""end_span"": 153, ""type"": ""Protein""}, {""token"": ""granulocyte - macrophage colony - stimulating factor"", ""start_span"": 155, ""end_span"": 207, ""type"": ""Protein""}, {""token"": ""GM - CSF"", ""start_span"": 210, ""end_span"": 218, ""type"": ""Protein""}, {""token"": ""erythropoietin"", ""start_span"": 224, ""end_span"": 238, ""type"": ""Protein""}, {""token"": ""Ep"", ""start_span"": 241, ""end_span"": 243, ""type"": ""Protein""}, {""token"": ""c - kit ligand"", ""start_span"": 261, ""end_span"": 275, ""type"": ""Protein""}]"	train
In the present study, analysis of the interleukin - 2 ( IL - 2) gene activation shows that naive human helper T cells ( cord blood CD4 + T cells, adult CD4 + CD45RO - T cells) regulate IL - 2 transcription by a mechanism involving both a silencer and an activator acting on the purine - rich IL - 2 promoter elements ( NF - AT binding sites).	interleukin - 2,38,53,Protein	IL - 2,56,62,Protein	CD4,131,134,Protein	CD4,152,155,Protein	CD45RO,158,164,Protein	IL - 2,185,191,Protein	IL - 2,292,298,Protein	"[{""token"": ""interleukin - 2"", ""start_span"": 38, ""end_span"": 53, ""type"": ""Protein""}, {""token"": ""IL - 2"", ""start_span"": 56, ""end_span"": 62, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 131, ""end_span"": 134, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 152, ""end_span"": 155, ""type"": ""Protein""}, {""token"": ""CD45RO"", ""start_span"": 158, ""end_span"": 164, ""type"": ""Protein""}, {""token"": ""IL - 2"", ""start_span"": 185, ""end_span"": 191, ""type"": ""Protein""}, {""token"": ""IL - 2"", ""start_span"": 292, ""end_span"": 298, ""type"": ""Protein""}]"	train
Nuclear factor of activated T cells - family proteins ( NFAT1 / NFATp, NFATc, NFAT3, and NFAT4 / NFATx / NFATc3) play a key role in the transcription of cytokine genes and other genes during the immune response.	NFAT1,56,61,Protein	NFATp,64,69,Protein	NFATc,71,76,Protein	NFAT3,78,83,Protein	NFAT4,89,94,Protein	NFATx,97,102,Protein	NFATc3,105,111,Protein	"[{""token"": ""NFAT1"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Protein""}, {""token"": ""NFATp"", ""start_span"": 64, ""end_span"": 69, ""type"": ""Protein""}, {""token"": ""NFATc"", ""start_span"": 71, ""end_span"": 76, ""type"": ""Protein""}, {""token"": ""NFAT3"", ""start_span"": 78, ""end_span"": 83, ""type"": ""Protein""}, {""token"": ""NFAT4"", ""start_span"": 89, ""end_span"": 94, ""type"": ""Protein""}, {""token"": ""NFATx"", ""start_span"": 97, ""end_span"": 102, ""type"": ""Protein""}, {""token"": ""NFATc3"", ""start_span"": 105, ""end_span"": 111, ""type"": ""Protein""}]"	train
Along with our previous demonstration of both physical interactions between PTF gamma / PTF delta and TBP and the involvement of TFIIIB90 in the transcription of class III snRNA genes, these results are consistent with the notion that a TBP - containing complex related to TFIIIB is required for the transcription of class III snRNA genes, and acts through weak interaction with the four - subunit PTF.	PTF gamma,76,85,Protein	PTF delta,88,97,Protein	TBP,102,105,Protein	TFIIIB90,129,137,Protein	snRNA,172,177,Protein	TBP,237,240,Protein	snRNA,327,332,Protein	"[{""token"": ""PTF gamma"", ""start_span"": 76, ""end_span"": 85, ""type"": ""Protein""}, {""token"": ""PTF delta"", ""start_span"": 88, ""end_span"": 97, ""type"": ""Protein""}, {""token"": ""TBP"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Protein""}, {""token"": ""TFIIIB90"", ""start_span"": 129, ""end_span"": 137, ""type"": ""Protein""}, {""token"": ""snRNA"", ""start_span"": 172, ""end_span"": 177, ""type"": ""Protein""}, {""token"": ""TBP"", ""start_span"": 237, ""end_span"": 240, ""type"": ""Protein""}, {""token"": ""snRNA"", ""start_span"": 327, ""end_span"": 332, ""type"": ""Protein""}]"	train
V3 - BH10 neither blocked radiolabeled IL - 2 binding to IL - 2 receptors nor affected tyrosyl phosphorylation of several cellular proteins ( p120, p98, p96, p54, and p38), which is immediately induced by IL - 2 stimulation.	IL - 2,39,45,Protein	p120,142,146,Protein	p98,148,151,Protein	p96,153,156,Protein	p54,158,161,Protein	p38,167,170,Protein	IL - 2,205,211,Protein	"[{""token"": ""IL - 2"", ""start_span"": 39, ""end_span"": 45, ""type"": ""Protein""}, {""token"": ""p120"", ""start_span"": 142, ""end_span"": 146, ""type"": ""Protein""}, {""token"": ""p98"", ""start_span"": 148, ""end_span"": 151, ""type"": ""Protein""}, {""token"": ""p96"", ""start_span"": 153, ""end_span"": 156, ""type"": ""Protein""}, {""token"": ""p54"", ""start_span"": 158, ""end_span"": 161, ""type"": ""Protein""}, {""token"": ""p38"", ""start_span"": 167, ""end_span"": 170, ""type"": ""Protein""}, {""token"": ""IL - 2"", ""start_span"": 205, ""end_span"": 211, ""type"": ""Protein""}]"	train
Our previous studies showed that the exposure of human monocytes to E. chaffeensis induces the expression of interleukin - 1beta ( IL - 1beta), IL - 8, and IL - 10 genes in vitro but not the expression of tumor necrosis factor alpha ( TNF - alpha) and IL - 6 mRNAs.	interleukin - 1beta,109,128,Protein	IL - 1beta,131,141,Protein	IL - 8,144,150,Protein	IL - 10,156,163,Protein	tumor necrosis factor alpha,205,232,Protein	TNF - alpha,235,246,Protein	IL - 6,252,258,Protein	"[{""token"": ""interleukin - 1beta"", ""start_span"": 109, ""end_span"": 128, ""type"": ""Protein""}, {""token"": ""IL - 1beta"", ""start_span"": 131, ""end_span"": 141, ""type"": ""Protein""}, {""token"": ""IL - 8"", ""start_span"": 144, ""end_span"": 150, ""type"": ""Protein""}, {""token"": ""IL - 10"", ""start_span"": 156, ""end_span"": 163, ""type"": ""Protein""}, {""token"": ""tumor necrosis factor alpha"", ""start_span"": 205, ""end_span"": 232, ""type"": ""Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 235, ""end_span"": 246, ""type"": ""Protein""}, {""token"": ""IL - 6"", ""start_span"": 252, ""end_span"": 258, ""type"": ""Protein""}]"	train
"CsA neither inhibits the processing of the NF - kappa B1 precursor p105 to p50, nor does it "" stabilize "" the C - terminal portion of p105, I kappa B gamma, which is degraded during p105 processing to mature p50."	NF - kappa B1,43,56,Protein	p105,67,71,Protein	p50,75,78,Protein	p105,134,138,Protein	I kappa B gamma,140,155,Protein	p105,182,186,Protein	p50,208,211,Protein	"[{""token"": ""NF - kappa B1"", ""start_span"": 43, ""end_span"": 56, ""type"": ""Protein""}, {""token"": ""p105"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Protein""}, {""token"": ""p105"", ""start_span"": 134, ""end_span"": 138, ""type"": ""Protein""}, {""token"": ""I kappa B gamma"", ""start_span"": 140, ""end_span"": 155, ""type"": ""Protein""}, {""token"": ""p105"", ""start_span"": 182, ""end_span"": 186, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 208, ""end_span"": 211, ""type"": ""Protein""}]"	train
All fusions splice the 5 ' ends of the 3q21 genes into exon 2 of the EVI1 gene, an event that is similar to the normal intergenic splicing of MDS1 - EVI1 and to those previously documented in leukemias with t ( 3; 21) and t ( 3; 12), in which acute myelogenous leukemia 1 - EVI1 fusions and ETV6 - EVI1 fusions, respectively, occur.	EVI1,69,73,Protein	MDS1,142,146,Protein	EVI1,149,153,Protein	acute myelogenous leukemia 1,243,271,Protein	EVI1,274,278,Protein	ETV6,291,295,Protein	EVI1,298,302,Protein	"[{""token"": ""EVI1"", ""start_span"": 69, ""end_span"": 73, ""type"": ""Protein""}, {""token"": ""MDS1"", ""start_span"": 142, ""end_span"": 146, ""type"": ""Protein""}, {""token"": ""EVI1"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Protein""}, {""token"": ""acute myelogenous leukemia 1"", ""start_span"": 243, ""end_span"": 271, ""type"": ""Protein""}, {""token"": ""EVI1"", ""start_span"": 274, ""end_span"": 278, ""type"": ""Protein""}, {""token"": ""ETV6"", ""start_span"": 291, ""end_span"": 295, ""type"": ""Protein""}, {""token"": ""EVI1"", ""start_span"": 298, ""end_span"": 302, ""type"": ""Protein""}]"	train
Moreover, the mechanism of action of BHRF1 resembled that of Bcl - 2 and Bcl - xL as it inhibited TNF - and anti - Fas - induced activation of two enzymes participating in the apoptosis pathway, cytosolic phospholipase A2 and caspase - 3 / CPP32, but did not interfere with the activation of NF - kappaB - like transcription factors.	BHRF1,37,42,Protein	Bcl - 2,61,68,Protein	Bcl - xL,73,81,Protein	Fas,115,118,Protein	cytosolic phospholipase A2,195,221,Protein	caspase - 3,226,237,Protein	CPP32,240,245,Protein	"[{""token"": ""BHRF1"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Protein""}, {""token"": ""Bcl - 2"", ""start_span"": 61, ""end_span"": 68, ""type"": ""Protein""}, {""token"": ""Bcl - xL"", ""start_span"": 73, ""end_span"": 81, ""type"": ""Protein""}, {""token"": ""Fas"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Protein""}, {""token"": ""cytosolic phospholipase A2"", ""start_span"": 195, ""end_span"": 221, ""type"": ""Protein""}, {""token"": ""caspase - 3"", ""start_span"": 226, ""end_span"": 237, ""type"": ""Protein""}, {""token"": ""CPP32"", ""start_span"": 240, ""end_span"": 245, ""type"": ""Protein""}]"	train
Our studies now demonstrate that HTLV - 1 Tax activates the recently identified cellular kinases IkappaB kinase alpha ( IKKalpha) and IKKbeta, which normally phosphorylate IkappaB alpha on both of its N - terminal regulatory serines in response to tumor necrosis factor alpha ( TNF - alpha) and interleukin - 1 ( IL - 1) stimulation.	Tax,42,45,Protein	IkappaB kinase alpha,97,117,Protein	IKKalpha,120,128,Protein	IKKbeta,134,141,Protein	IkappaB alpha,172,185,Protein	tumor necrosis factor alpha,248,275,Protein	TNF - alpha,278,289,Protein	"[{""token"": ""Tax"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Protein""}, {""token"": ""IkappaB kinase alpha"", ""start_span"": 97, ""end_span"": 117, ""type"": ""Protein""}, {""token"": ""IKKalpha"", ""start_span"": 120, ""end_span"": 128, ""type"": ""Protein""}, {""token"": ""IKKbeta"", ""start_span"": 134, ""end_span"": 141, ""type"": ""Protein""}, {""token"": ""IkappaB alpha"", ""start_span"": 172, ""end_span"": 185, ""type"": ""Protein""}, {""token"": ""tumor necrosis factor alpha"", ""start_span"": 248, ""end_span"": 275, ""type"": ""Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 278, ""end_span"": 289, ""type"": ""Protein""}]"	train
To circumvent this problem, we developed an alternative procedure which allowed us to show that in neutrophils, LPS and TNFalpha induce a NF - kappaB DNA - binding activity which essentially consists of p50 / RelA dimers, and that IFNgamma promotes the binding of STAT1 homodimers to the IFNgamma response region of the FcgammaRI promoter.	TNFalpha,120,128,Protein	p50,203,206,Protein	RelA,209,213,Protein	IFNgamma,231,239,Protein	STAT1,264,269,Protein	IFNgamma,288,296,Protein	FcgammaRI,320,329,Protein	"[{""token"": ""TNFalpha"", ""start_span"": 120, ""end_span"": 128, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 203, ""end_span"": 206, ""type"": ""Protein""}, {""token"": ""RelA"", ""start_span"": 209, ""end_span"": 213, ""type"": ""Protein""}, {""token"": ""IFNgamma"", ""start_span"": 231, ""end_span"": 239, ""type"": ""Protein""}, {""token"": ""STAT1"", ""start_span"": 264, ""end_span"": 269, ""type"": ""Protein""}, {""token"": ""IFNgamma"", ""start_span"": 288, ""end_span"": 296, ""type"": ""Protein""}, {""token"": ""FcgammaRI"", ""start_span"": 320, ""end_span"": 329, ""type"": ""Protein""}]"	train
Whereas the NF - kappaB binding activity in Tax - expressing T - cell lines consisted mostly of p50 / c - Rel, fresh ATL samples contained p50 / p50 and p50 / p65 heterodimers.	Tax,44,47,Protein	p50,96,99,Protein	c - Rel,102,109,Protein	p50,139,142,Protein	p50,145,148,Protein	p50,153,156,Protein	p65,159,162,Protein	"[{""token"": ""Tax"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 96, ""end_span"": 99, ""type"": ""Protein""}, {""token"": ""c - Rel"", ""start_span"": 102, ""end_span"": 109, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 139, ""end_span"": 142, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 145, ""end_span"": 148, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 153, ""end_span"": 156, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 159, ""end_span"": 162, ""type"": ""Protein""}]"	valid
Comparison of KG1 to the PMA - unresponsive subline KG1a reveals differences in expression of TNF receptors 1 and 2; PKC isoforms alpha, beta I, beta II, and mu; and RelB, suggesting that these components / pathways are important for DC differentiation.	TNF receptors 1,94,109,Protein	2,114,115,Protein	PKC isoforms alpha,117,135,Protein	beta I,137,143,Protein	beta II,145,152,Protein	mu,158,160,Protein	RelB,166,170,Protein	"[{""token"": ""TNF receptors 1"", ""start_span"": 94, ""end_span"": 109, ""type"": ""Protein""}, {""token"": ""2"", ""start_span"": 114, ""end_span"": 115, ""type"": ""Protein""}, {""token"": ""PKC isoforms alpha"", ""start_span"": 117, ""end_span"": 135, ""type"": ""Protein""}, {""token"": ""beta I"", ""start_span"": 137, ""end_span"": 143, ""type"": ""Protein""}, {""token"": ""beta II"", ""start_span"": 145, ""end_span"": 152, ""type"": ""Protein""}, {""token"": ""mu"", ""start_span"": 158, ""end_span"": 160, ""type"": ""Protein""}, {""token"": ""RelB"", ""start_span"": 166, ""end_span"": 170, ""type"": ""Protein""}]"	valid
Furthermore, CD40 ligation of a HLA - A2 +, MelanA / MART1 + MM cell line enhanced its susceptibility to specific lysis by a HLA - A2 - restricted, MelanA / MART - 1 - specific CTL clone.	CD40,13,17,Protein	HLA - A2,32,40,Protein	MelanA,44,50,Protein	MART1,53,58,Protein	HLA - A2,125,133,Protein	MelanA,148,154,Protein	MART - 1,157,165,Protein	"[{""token"": ""CD40"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Protein""}, {""token"": ""HLA - A2"", ""start_span"": 32, ""end_span"": 40, ""type"": ""Protein""}, {""token"": ""MelanA"", ""start_span"": 44, ""end_span"": 50, ""type"": ""Protein""}, {""token"": ""MART1"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Protein""}, {""token"": ""HLA - A2"", ""start_span"": 125, ""end_span"": 133, ""type"": ""Protein""}, {""token"": ""MelanA"", ""start_span"": 148, ""end_span"": 154, ""type"": ""Protein""}, {""token"": ""MART - 1"", ""start_span"": 157, ""end_span"": 165, ""type"": ""Protein""}]"	valid
Exogenous IL - 2, which restitutes the proliferative response of the anti - CD3 - and anti - CD28 - treated Rel - / - T cells, restores production of IL - 5, TNF - alpha, and IFN - gamma, but not IL - 3 and GM - CSF expression to approximately normal levels.	IL - 2,10,16,Protein	CD28,93,97,Protein	IL - 5,150,156,Protein	TNF - alpha,158,169,Protein	IFN - gamma,175,186,Protein	IL - 3,196,202,Protein	GM - CSF,207,215,Protein	"[{""token"": ""IL - 2"", ""start_span"": 10, ""end_span"": 16, ""type"": ""Protein""}, {""token"": ""CD28"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Protein""}, {""token"": ""IL - 5"", ""start_span"": 150, ""end_span"": 156, ""type"": ""Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 158, ""end_span"": 169, ""type"": ""Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 175, ""end_span"": 186, ""type"": ""Protein""}, {""token"": ""IL - 3"", ""start_span"": 196, ""end_span"": 202, ""type"": ""Protein""}, {""token"": ""GM - CSF"", ""start_span"": 207, ""end_span"": 215, ""type"": ""Protein""}]"	valid
Galectin - 3 is a beta - galactoside - binding lectin previously designated as epsilon BP ( IgE - binding protein), CBP35, Mac - 2, L - 29, and L - 34, and its expression has been associated with various physiological and pathological processes, including cell growth, tumor transformation, and metastasis.	Galectin - 3,0,12,Protein	epsilon BP,79,89,Protein	IgE - binding protein,92,113,Protein	CBP35,116,121,Protein	Mac - 2,123,130,Protein	L - 29,132,138,Protein	L - 34,144,150,Protein	"[{""token"": ""Galectin - 3"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Protein""}, {""token"": ""epsilon BP"", ""start_span"": 79, ""end_span"": 89, ""type"": ""Protein""}, {""token"": ""IgE - binding protein"", ""start_span"": 92, ""end_span"": 113, ""type"": ""Protein""}, {""token"": ""CBP35"", ""start_span"": 116, ""end_span"": 121, ""type"": ""Protein""}, {""token"": ""Mac - 2"", ""start_span"": 123, ""end_span"": 130, ""type"": ""Protein""}, {""token"": ""L - 29"", ""start_span"": 132, ""end_span"": 138, ""type"": ""Protein""}, {""token"": ""L - 34"", ""start_span"": 144, ""end_span"": 150, ""type"": ""Protein""}]"	valid
Newly translated STAT1 binds in equilibrium fashion to STAT2 and STAT3, but we show that STAT2 and STAT3 exist in separate heterocomplexes with STAT1, consistent with a model in which STAT1 contains a common binding site for other STAT proteins.	STAT1,17,22,Protein	STAT2,55,60,Protein	STAT3,65,70,Protein	STAT2,89,94,Protein	STAT3,99,104,Protein	STAT1,144,149,Protein	STAT1,184,189,Protein	"[{""token"": ""STAT1"", ""start_span"": 17, ""end_span"": 22, ""type"": ""Protein""}, {""token"": ""STAT2"", ""start_span"": 55, ""end_span"": 60, ""type"": ""Protein""}, {""token"": ""STAT3"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Protein""}, {""token"": ""STAT2"", ""start_span"": 89, ""end_span"": 94, ""type"": ""Protein""}, {""token"": ""STAT3"", ""start_span"": 99, ""end_span"": 104, ""type"": ""Protein""}, {""token"": ""STAT1"", ""start_span"": 144, ""end_span"": 149, ""type"": ""Protein""}, {""token"": ""STAT1"", ""start_span"": 184, ""end_span"": 189, ""type"": ""Protein""}]"	valid
MDS1 / EVI1 enhances TGF - beta1 signaling and strengthens its growth - inhibitory effect but the leukemia - associated fusion protein AML1 / MDS1 / EVI1, product of the t ( 3; 21), abrogates growth - inhibition in response to TGF - beta1.	MDS1,0,4,Protein	EVI1,7,11,Protein	TGF - beta1,21,32,Protein	AML1,135,139,Protein	MDS1,142,146,Protein	EVI1,149,153,Protein	TGF - beta1,227,238,Protein	"[{""token"": ""MDS1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Protein""}, {""token"": ""EVI1"", ""start_span"": 7, ""end_span"": 11, ""type"": ""Protein""}, {""token"": ""TGF - beta1"", ""start_span"": 21, ""end_span"": 32, ""type"": ""Protein""}, {""token"": ""AML1"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Protein""}, {""token"": ""MDS1"", ""start_span"": 142, ""end_span"": 146, ""type"": ""Protein""}, {""token"": ""EVI1"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Protein""}, {""token"": ""TGF - beta1"", ""start_span"": 227, ""end_span"": 238, ""type"": ""Protein""}]"	test
Furthermore, we show that whereas the expression of the fusion protein AML1 / MDS1 / EVI1 completely abrogates the growth - inhibitory effect of TGF - beta1 and allows 32Dcl3 cells to proliferate, expression of the normal protein MDS1 / EVI1 has the opposite effect, and it strengthens the response of cells to the growth - inhibitory effect of TGF - beta1.	AML1,71,75,Protein	MDS1,78,82,Protein	EVI1,85,89,Protein	TGF - beta1,145,156,Protein	MDS1,230,234,Protein	EVI1,237,241,Protein	TGF - beta1,345,356,Protein	"[{""token"": ""AML1"", ""start_span"": 71, ""end_span"": 75, ""type"": ""Protein""}, {""token"": ""MDS1"", ""start_span"": 78, ""end_span"": 82, ""type"": ""Protein""}, {""token"": ""EVI1"", ""start_span"": 85, ""end_span"": 89, ""type"": ""Protein""}, {""token"": ""TGF - beta1"", ""start_span"": 145, ""end_span"": 156, ""type"": ""Protein""}, {""token"": ""MDS1"", ""start_span"": 230, ""end_span"": 234, ""type"": ""Protein""}, {""token"": ""EVI1"", ""start_span"": 237, ""end_span"": 241, ""type"": ""Protein""}, {""token"": ""TGF - beta1"", ""start_span"": 345, ""end_span"": 356, ""type"": ""Protein""}]"	test
Although BCL - 6 ( -) / syn - 1 ( +) RS cells of HIV - HD express CD40, they are not surrounded by CD40 ligand - positive ( CD40L +) reactive T lymphocytes, which, in HD of the general population, are thought to regulate the disease phenotype through CD40 / CD40L interactions.	BCL - 6,9,16,Protein	syn - 1,24,31,Protein	CD40,66,70,Protein	CD40 ligand,99,110,Protein	CD40L,124,129,Protein	CD40,251,255,Protein	CD40L,258,263,Protein	"[{""token"": ""BCL - 6"", ""start_span"": 9, ""end_span"": 16, ""type"": ""Protein""}, {""token"": ""syn - 1"", ""start_span"": 24, ""end_span"": 31, ""type"": ""Protein""}, {""token"": ""CD40"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Protein""}, {""token"": ""CD40 ligand"", ""start_span"": 99, ""end_span"": 110, ""type"": ""Protein""}, {""token"": ""CD40L"", ""start_span"": 124, ""end_span"": 129, ""type"": ""Protein""}, {""token"": ""CD40"", ""start_span"": 251, ""end_span"": 255, ""type"": ""Protein""}, {""token"": ""CD40L"", ""start_span"": 258, ""end_span"": 263, ""type"": ""Protein""}]"	test
CONCLUSIONS: HCS forcefully blocks the production of IL - 2; the IL - 2R alpha - chain; and Jak1, Jak3, Stat1, Stat3, and Stat5 expression.	IL - 2,53,59,Protein	IL - 2R alpha - chain,65,86,Protein	Jak1,92,96,Protein	Jak3,98,102,Protein	Stat1,104,109,Protein	Stat3,111,116,Protein	Stat5,122,127,Protein	"[{""token"": ""IL - 2"", ""start_span"": 53, ""end_span"": 59, ""type"": ""Protein""}, {""token"": ""IL - 2R alpha - chain"", ""start_span"": 65, ""end_span"": 86, ""type"": ""Protein""}, {""token"": ""Jak1"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Protein""}, {""token"": ""Jak3"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Protein""}, {""token"": ""Stat1"", ""start_span"": 104, ""end_span"": 109, ""type"": ""Protein""}, {""token"": ""Stat3"", ""start_span"": 111, ""end_span"": 116, ""type"": ""Protein""}, {""token"": ""Stat5"", ""start_span"": 122, ""end_span"": 127, ""type"": ""Protein""}]"	test
We reasoned that selective IFN responsiveness of the first STAT family member ( Stat1) and Stat1 - dependent immune - response genes such as intercellular adhesion molecule - 1 ( ICAM - 1), IFN regulatory factor - 1 ( IRF - 1), and Stat1 itself in airway epithelial cells provides a basis for detecting cytokine signaling abnormalities in inflammatory airway disease.	Stat1,80,85,Protein	Stat1,91,96,Protein	intercellular adhesion molecule - 1,141,176,Protein	ICAM - 1,179,187,Protein	IFN regulatory factor - 1,190,215,Protein	IRF - 1,218,225,Protein	Stat1,232,237,Protein	"[{""token"": ""Stat1"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Protein""}, {""token"": ""Stat1"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Protein""}, {""token"": ""intercellular adhesion molecule - 1"", ""start_span"": 141, ""end_span"": 176, ""type"": ""Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 179, ""end_span"": 187, ""type"": ""Protein""}, {""token"": ""IFN regulatory factor - 1"", ""start_span"": 190, ""end_span"": 215, ""type"": ""Protein""}, {""token"": ""IRF - 1"", ""start_span"": 218, ""end_span"": 225, ""type"": ""Protein""}, {""token"": ""Stat1"", ""start_span"": 232, ""end_span"": 237, ""type"": ""Protein""}]"	test
We identified this 92 - kDa protein as STAT5, but not as STATs1, 3, and 6 nor c - fes and vav protooncogene products, and demonstrated its translocation to the nucleus, enhancement of specific DNA binding capacity, and potentiation of trancriptional activity by GM - CSF.	STAT5,39,44,Protein	STATs1,57,63,Protein	3,65,66,Protein	6,72,73,Protein	c - fes,78,85,Protein	vav,90,93,Protein	GM - CSF,262,270,Protein	"[{""token"": ""STAT5"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Protein""}, {""token"": ""STATs1"", ""start_span"": 57, ""end_span"": 63, ""type"": ""Protein""}, {""token"": ""3"", ""start_span"": 65, ""end_span"": 66, ""type"": ""Protein""}, {""token"": ""6"", ""start_span"": 72, ""end_span"": 73, ""type"": ""Protein""}, {""token"": ""c - fes"", ""start_span"": 78, ""end_span"": 85, ""type"": ""Protein""}, {""token"": ""vav"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Protein""}, {""token"": ""GM - CSF"", ""start_span"": 262, ""end_span"": 270, ""type"": ""Protein""}]"	test
From a consecutive series of 350 cases of adult de novo acute myeloid leukemia ( AML), we identified 20 cases ( 6%) with a unique immunophenotype: CD33 +, CD56 +, CD11a +, CD13lo, CD15lo, CD34 + / -, HLA - DR -, CD16 -.	CD33,147,151,Protein	CD56,155,159,Protein	CD11a,163,168,Protein	CD13lo,172,178,Protein	CD15lo,180,186,Protein	CD34,188,192,Protein	CD16,212,216,Protein	"[{""token"": ""CD33"", ""start_span"": 147, ""end_span"": 151, ""type"": ""Protein""}, {""token"": ""CD56"", ""start_span"": 155, ""end_span"": 159, ""type"": ""Protein""}, {""token"": ""CD11a"", ""start_span"": 163, ""end_span"": 168, ""type"": ""Protein""}, {""token"": ""CD13lo"", ""start_span"": 172, ""end_span"": 178, ""type"": ""Protein""}, {""token"": ""CD15lo"", ""start_span"": 180, ""end_span"": 186, ""type"": ""Protein""}, {""token"": ""CD34"", ""start_span"": 188, ""end_span"": 192, ""type"": ""Protein""}, {""token"": ""CD16"", ""start_span"": 212, ""end_span"": 216, ""type"": ""Protein""}]"	test
Here we report that binding of human IL - 2 to its binding site leads to transcriptional activation of the macrophage CSF ( M - CSF) gene in Mo resulting in accumulation of M - CSF mRNA and subsequent release of bioactive M - CSF protein as demonstrated by ELISA and inhibition of IL - 2 induced release of an activity - stimulating growth of monocyte - type colonies by a neutralizing anti - M - CSF antibody.	IL - 2,37,43,Protein	macrophage CSF,107,121,Protein	M - CSF,124,131,Protein	M - CSF,173,180,Protein	M - CSF,222,229,Protein	IL - 2,281,287,Protein	M - CSF,393,400,Protein	"[{""token"": ""IL - 2"", ""start_span"": 37, ""end_span"": 43, ""type"": ""Protein""}, {""token"": ""macrophage CSF"", ""start_span"": 107, ""end_span"": 121, ""type"": ""Protein""}, {""token"": ""M - CSF"", ""start_span"": 124, ""end_span"": 131, ""type"": ""Protein""}, {""token"": ""M - CSF"", ""start_span"": 173, ""end_span"": 180, ""type"": ""Protein""}, {""token"": ""M - CSF"", ""start_span"": 222, ""end_span"": 229, ""type"": ""Protein""}, {""token"": ""IL - 2"", ""start_span"": 281, ""end_span"": 287, ""type"": ""Protein""}, {""token"": ""M - CSF"", ""start_span"": 393, ""end_span"": 400, ""type"": ""Protein""}]"	test
Elevated cAMP did not prevent nuclear translocation of p50 / p65 and c - Rel / p65 heterodimers, decrease nuclear translocation of p65, or significantly modify TNFalpha - induced phosphorylation of p65.	p50,55,58,Protein	p65,61,64,Protein	c - Rel,69,76,Protein	p65,79,82,Protein	p65,131,134,Protein	TNFalpha,160,168,Protein	p65,198,201,Protein	"[{""token"": ""p50"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Protein""}, {""token"": ""c - Rel"", ""start_span"": 69, ""end_span"": 76, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 131, ""end_span"": 134, ""type"": ""Protein""}, {""token"": ""TNFalpha"", ""start_span"": 160, ""end_span"": 168, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 198, ""end_span"": 201, ""type"": ""Protein""}]"	test
A dramatic increase in the intracellular levels of NF - kappaB subunits c - Rel and NF - kappaB2 p100 and a moderate increase in NF - kappaB2 p52 and RelA ( p65) were detected in HIV - 1 - infected cells, whereas NF - kappaB1 p105 / p50 levels were not altered relative to the levels in uninfected cells.	c - Rel,72,79,Protein	NF - kappaB2 p100,84,101,Protein	NF - kappaB2 p52,129,145,Protein	RelA,150,154,Protein	p65,157,160,Protein	NF - kappaB1 p105,213,230,Protein	p50,233,236,Protein	"[{""token"": ""c - Rel"", ""start_span"": 72, ""end_span"": 79, ""type"": ""Protein""}, {""token"": ""NF - kappaB2 p100"", ""start_span"": 84, ""end_span"": 101, ""type"": ""Protein""}, {""token"": ""NF - kappaB2 p52"", ""start_span"": 129, ""end_span"": 145, ""type"": ""Protein""}, {""token"": ""RelA"", ""start_span"": 150, ""end_span"": 154, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 157, ""end_span"": 160, ""type"": ""Protein""}, {""token"": ""NF - kappaB1 p105"", ""start_span"": 213, ""end_span"": 230, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 233, ""end_span"": 236, ""type"": ""Protein""}]"	test
"Tumor necrosis factor receptor - 1 ( TNFR - 1) and CD95 ( also called Fas or APO - 1) are cytokine receptors that engage the apoptosis pathway through a region of intracellular homology, designated the "" death domain. "" Another death domain - containing member of the TNFR family, death receptor 3 ( DR3), was identified and was shown to induce both apoptosis and activation of nuclear factor kappaB."	Tumor necrosis factor receptor - 1,0,34,Protein	TNFR - 1,37,45,Protein	CD95,51,55,Protein	Fas,70,73,Protein	APO - 1,77,84,Protein	death receptor 3,281,297,Protein	DR3,300,303,Protein	"[{""token"": ""Tumor necrosis factor receptor - 1"", ""start_span"": 0, ""end_span"": 34, ""type"": ""Protein""}, {""token"": ""TNFR - 1"", ""start_span"": 37, ""end_span"": 45, ""type"": ""Protein""}, {""token"": ""CD95"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Protein""}, {""token"": ""Fas"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Protein""}, {""token"": ""APO - 1"", ""start_span"": 77, ""end_span"": 84, ""type"": ""Protein""}, {""token"": ""death receptor 3"", ""start_span"": 281, ""end_span"": 297, ""type"": ""Protein""}, {""token"": ""DR3"", ""start_span"": 300, ""end_span"": 303, ""type"": ""Protein""}]"	test
p52 and RelB were detected in the nuclei in both CD1a + and CD68 + cells from the T cell area, whereas p50 was found only in CD68 - and CD1a - cells.	p52,0,3,Protein	RelB,8,12,Protein	CD1a,49,53,Protein	CD68,60,64,Protein	p50,103,106,Protein	CD68,125,129,Protein	CD1a,136,140,Protein	"[{""token"": ""p52"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Protein""}, {""token"": ""RelB"", ""start_span"": 8, ""end_span"": 12, ""type"": ""Protein""}, {""token"": ""CD1a"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Protein""}, {""token"": ""CD68"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Protein""}, {""token"": ""CD68"", ""start_span"": 125, ""end_span"": 129, ""type"": ""Protein""}, {""token"": ""CD1a"", ""start_span"": 136, ""end_span"": 140, ""type"": ""Protein""}]"	test
Constitutive binding of further factor proteins to DNA, such as JunD, c - Fos and FosB, was detected in several patients whereas the localisation and DNA binding of other factors such as c - Jun, RelA / p65 and c - Rel was unaltered.	JunD,64,68,Protein	c - Fos,70,77,Protein	FosB,82,86,Protein	c - Jun,187,194,Protein	RelA,196,200,Protein	p65,203,206,Protein	c - Rel,211,218,Protein	"[{""token"": ""JunD"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Protein""}, {""token"": ""c - Fos"", ""start_span"": 70, ""end_span"": 77, ""type"": ""Protein""}, {""token"": ""FosB"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Protein""}, {""token"": ""c - Jun"", ""start_span"": 187, ""end_span"": 194, ""type"": ""Protein""}, {""token"": ""RelA"", ""start_span"": 196, ""end_span"": 200, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 203, ""end_span"": 206, ""type"": ""Protein""}, {""token"": ""c - Rel"", ""start_span"": 211, ""end_span"": 218, ""type"": ""Protein""}]"	test
